By focusing on innovative, long-lasting pain relief methods, Brixton is well-positioned to contribute to the shift away from opioid dependence. The company’s technologies align with the objectives of ...
Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...